Investing
Icahn Enterprises LP’s stock rose 14% Friday to put it on track for its biggest one-day gain since May 5, after the company’s third-quarter...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
Published: March 3, 2025 at 5:34 p.m. ET A backlash over President Donald Trump’s plan to include three small and relatively risky tokens in an...
Investing
Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue at the...
Investing
Last Updated: March 3, 2025 at 10:21 p.m. ETFirst Published: March 3, 2025 at 4:58 p.m. ET Kids who are obsessed with football may dream of...
Investing
Lumen Technologies Inc. shares sold off sharply in the wake of earnings, but the telecommunication company’s chief executive has been buying. CEO Kate Johnson...
Investing
Perdoceo Education (PRDO) had another great quarterly showing. Indeed, driven by contributions from its recent acquisitions of Coding Dojo and California Southern University and...
Investing
Gold has more reasons to rise in the wake of the Federal Reserve’s decision in November to stand pat on interest rates, helping to...
Investing
Oil futures finished higher on Thursday, with weakness in the U.S. dollar following the Federal Reserve’s decision to leave a key interest rate unchanged,...
Investing
By Paul Ziobro Shares of Trupanion jumped in late trading on Thursday after the pet insurance company posted a narrower-than-expected third-quarter loss on a...
Investing
“Time to Buy Bonds” proclaims the cover of this week’s Barron’s. A recent New York Times headline reads, “Bonds Have Been Awful. It’s a...
Investing
By Ben Glickman Consolidated Edison’s third-quarter profit sank on lower revenues. The New York-based utility company logged a third-quarter profit of $526 million, or...
Investing
Week in Review Asian equities were mostly up this week following US stocks higher on a more dovish tone from the US Fed. China’s...
Investing
By Colin Kellaher Kronos Bio is shedding about 19% of its staff as the clinical-stage biopharmaceutical moves to extend its cash runway following positive...
